Akebia Therapeutics Earnings Date, Estimates & History (NASDAQ:AKBA)

Earnings

Akebia Therapeutics has confirmed that its next quarterly earnings report will be published on Tuesday, March 10th, 2020. Akebia Therapeutics will be holding an earnings conference call on Tuesday, March 10th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Akebia Therapeutics Earnings Estimates and Actuals by Quarter

Akebia Therapeutics (NASDAQ:AKBA) Earnings Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2020	1	($0.27)	($0.27)	($0.27)
Q2 2020	1	($0.49)	($0.49)	($0.49)
Q3 2020	1	($0.28)	($0.28)	($0.28)
Q4 2020	1	($0.15)	($0.15)	($0.15)
Q1 2021	1	($0.41)	($0.41)	($0.41)
Q2 2021	1	($0.40)	($0.40)	($0.40)
Q3 2021	1	($0.38)	($0.38)	($0.38)

Akebia Therapeutics (NASDAQ AKBA) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Reported EPS	GAAP EPS	Revenue Estimate	Actual Revenue	Conference Call	Details
3/10/2020 (Confirmed)		($0.44)					Register (Before Market Opens)
11/12/2019	Q3 2019	($0.37)	($0.4592)	($0.10)	$93.94 million	$91.98 million	Transcript
8/8/2019	Q2 2019	($0.35)	($0.30)	($0.11)	$88.35 million	$100.80 million	N/A
5/9/2019	3/31/2019	($0.42)	($0.44)	($0.26)	$83.69 million	$72.67 million	N/A
3/26/2019	Q4 2018	($0.27)	($0.91)	($0.89)	$78.87 million	$59.85 million	N/A
11/8/2018	Q3	($0.6410)	($0.46)	($0.46)	$39.71 million	$53.17 million	N/A
8/8/2018	Q2 2018	($0.51)	($0.60)	($0.60)	$48.75 million	$48.79 million	N/A
5/9/2018	Q1 2018	($0.49)	($0.48)	($0.48)	$47.80 million	$45.93 million	N/A
3/12/2018	Q4 2017	($0.36)	$0.25	$0.25	$66.00 million	$87.32 million	Transcript
11/8/2017	Q3 2017	($0.56)	($0.49)	($0.49)	$34.00 million	$41.28 million	N/A
8/8/2017	Q2 2017	($0.89)	($0.53)	($0.53)	$26.50 million	$28.52 million	N/A
5/9/2017	Q1 2017	($0.15)	($1.15)	($1.15)	$16.50 million	$20.87 million	N/A
3/6/2017	Q4 2016	$0.77	($0.99)	($0.99)	$125.00 million	$1.54 million	Listen
11/9/2016	Q3	($1.09)	($0.96)	($0.96)			N/A
8/8/2016	Q2 2016	($0.57)	($0.95)	($0.95)	$6.00 million		N/A
5/5/2016	Q1 2016	($0.43)	($0.70)	($0.70)	$9.00 million		N/A
3/14/2016	Q415	($0.28)	($0.66)	($0.66)	$11.60 million		Listen
11/9/2015	Q3	($0.52)	($0.68)	($0.68)			N/A
8/11/2015	Q215	($0.51)	($0.40)	($0.40)			N/A
5/11/2015	Q1 2015	($0.57)	($0.53)	($0.53)			N/A
3/4/2015	Q414	($0.66)	($0.52)	($0.52)			N/A
11/10/2014	Q314	($0.45)	($0.47)	($0.47)			N/A
8/11/2014	Q2 2014	($0.34)	($0.39)	($0.39)			N/A
5/12/2014	Q1 2014		($43.37)	($43.37)			N/A

(Earnings results data provided by Zacks Investment Research)